Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by Litemuppon Nov 30, 2016 11:04pm
183 Views
Post# 25538084

Hoping for the best

Hoping for the bestHello everyone I just signed up on stockhouse and have been following this board for a while. Lot of conversations, lots of back and forth, lots of people with a positive outlook and even more people with negative outlook to balance the positive outlook which some call pumping. I have looked up financial information of a lot of the mj plays and frankly they all have pretty shaky numbers. Numbers that would fail most financial litmus tests. As far as NF is concerned I have taken a small position today at 15 cents and based on my analysis over the last few days, nothing troublesome apart from the CEO planning on selling some stake to possibly invest back into NF one would hope. As far as this spin off is concerned, I have a feeling they will list it close to the legalization of mj in Canada. Till then they will develop the concept so that when it launches it will follow the foot steps of the NF in the US which by that time will be fully operational and successful. No one knows what the future holds, one aspect I like about NF is that it's not another mj company that is promising the world, instead they are operating in a niche where cost of entry is high requiring significant real estate investment and grower expertise which NF has. If this organization continues to do what they are doing for the next 6 months, they will easily be a lot higher than where they sit right now. Wish everyone here luck.
Bullboard Posts